Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) Return on Sales (2023 - 2025)

Zenas BioPharma has reported Return on Sales over the past 3 years, most recently at 1.08% for Q4 2025.

  • Quarterly results put Return on Sales at 1.08% for Q4 2025, up 1238.0% from a year ago — trailing twelve months through Dec 2025 was 1.08% (up 3326.0% YoY), and the annual figure for FY2025 was 1.08%, up 3335.0%.
  • Return on Sales for Q4 2025 was 1.08% at Zenas BioPharma, up from 12.92% in the prior quarter.
  • Over the last five years, Return on Sales for ZBIO hit a ceiling of 1.08% in Q4 2025 and a floor of 12.92% in Q3 2025.
  • Median Return on Sales over the past 3 years was 3.36% (2025), compared with a mean of 5.57%.
  • Peak annual rise in Return on Sales hit 1238bps in 2025, while the deepest fall reached -1096bps in 2025.
  • Zenas BioPharma's Return on Sales stood at 0.71% in 2023, then crashed by -1687bps to 11.31% in 2024, then skyrocketed by 110bps to 1.08% in 2025.
  • The last three reported values for Return on Sales were 1.08% (Q4 2025), 12.92% (Q3 2025), and 12.06% (Q2 2025) per Business Quant data.